PLIANT THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Pliant Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Pliant Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $28.1M, a 1487% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $28.1M +$26.3M +1487% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $28.9M +$24.7M +590% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $24.2M +$19.4M +403% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $1.21M -$4.21M -77.7% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $1.77M -$4.25M -70.6% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.19M -$1.46M -25.9% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $4.81M -$1.27M -20.9% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $5.42M -$908K -14.3% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $6.02M Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $5.65M Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $6.09M Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $6.33M +$6.33M Dec 31, 2021 10-K 2023-03-09
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.